RJA
IXJ icon

Raymond James & Associates’s iShares Global Healthcare ETF IXJ Stock Holding History

Raymond James & Associates’s Portfolio IXJ Stock Details IXJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$6.52M Buy
66,445
+2,223
+3% +$216K ﹤0.01% 1474
2024
Q2 		$5.96M Buy
64,222
+7,067
+12% +$645K ﹤0.01% 1467
2024
Q1 		$5.32M Buy
57,155
+6,503
+13% +$588K ﹤0.01% 1535
2023
Q4 		$4.39M Buy
50,652
+2,810
+6% +$233K ﹤0.01% 1621
2023
Q3 		$3.94M Buy
47,842
+152
+0.3% +$12.9K ﹤0.01% 1614
2023
Q2 		$4.05M Sell
47,690
-662
-1% -$56.5K ﹤0.01% 1622
2023
Q1 		$4.03M Sell
48,352
-44
-0.1% -$3.65K ﹤0.01% 1612
2022
Q4 		$4.11M Sell
48,396
-286
-0.6% -$23.6K ﹤0.01% 1533
2022
Q3 		$3.67M Buy
48,682
+226
+0.5% +$18.3K ﹤0.01% 1588
2022
Q2 		$3.93M Sell
48,456
-932
-2% -$77.9K ﹤0.01% 1556
2022
Q1 		$4.33M Buy
49,388
+341
+0.7% +$28.8K ﹤0.01% 1612
2021
Q4 		$4.43M Buy
49,047
+2,954
+6% +$255K ﹤0.01% 1643
2021
Q3 		$3.86M Buy
46,093
+4,343
+10% +$376K ﹤0.01% 1665
2021
Q2 		$3.47M Buy
41,750
+4,837
+13% +$391K ﹤0.01% 1742
2021
Q1 		$2.85M Sell
36,913
-948
-3% -$73K ﹤0.01% 1786
2020
Q4 		$2.89M Sell
37,861
-671
-2% -$49.4K ﹤0.01% 1663
2020
Q3 		$2.77M Sell
38,532
-23,773
-38% -$1.7M ﹤0.01% 1555
2020
Q2 		$4.29M Buy
62,305
+1,736
+3% +$117K 0.01% 1281
2020
Q1 		$3.69M Sell
60,569
-1,172
-2% -$77.3K 0.01% 1208
2019
Q4 		$4.25M Sell
61,741
-1,150
-2% -$74.6K 0.01% 1358
2019
Q3 		$3.84M Sell
62,891
-5,960
-9% -$364K 0.01% 1377
2019
Q2 		$4.25M Sell
68,851
-44,595
-39% -$2.67M 0.01% 1312
2019
Q1 		$6.93M Buy
113,446
+2,306
+2% +$137K 0.01% 1014
2018
Q4 		$6.3M Buy
111,140
+547
+0.5% +$32.7K 0.01% 989
2018
Q3 		$6.96M Buy
110,593
+1,409
+1% +$85.1K 0.01% 1022
2018
Q2 		$6.16M Sell
109,184
-38,584
-26% -$2.18M 0.01% 1066
2018
Q1 		$8.23M Buy
147,768
+57,162
+63% +$3.29M 0.01% 882
2017
Q4 		$5.1M Buy
90,606
+41,126
+83% +$2.31M 0.01% 1115
2017
Q3 		$2.78M Buy
49,480
+2,864
+6% +$158K 0.01% 1423
2017
Q2 		$2.55M Sell
46,616
-2,418
-5% -$128K 0.01% 1414
2017
Q1 		$2.52M Sell
49,034
-5,064
-9% -$254K 0.01% 1394
2016
Q4 		$2.56M Buy
54,098
+45,450
+526% +$2.18M 0.01% 1338
2016
Q3 		$436K Buy
8,648
+1,234
+17% +$63.4K ﹤0.01% 2378
2016
Q2 		$374K Sell
7,414
-144
-2% -$7.18K ﹤0.01% 2266
2016
Q1 		$364K Buy
+7,558
New +$360K ﹤0.01% 2220
2014
Q2 		– Sell
-27,664
Closed -$1.26M – 2202
2014
Q1 		$1.26M Buy
27,664
+182
+0.7% +$8.12K 0.01% 1294
2013
Q4 		$1.18M Buy
27,482
+814
+3% +$33.8K 0.01% 1234
2013
Q3 		$1.06M Buy
26,668
+3,580
+16% +$140K 0.01% 1231
2013
Q2 		$856K Buy
+23,088
New +$880K 0.01% 1243

Other funds holding IXJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James & Associates's IXJ Position: Q3 2024 in Review

Raymond James & Associates increased its iShares Global Healthcare ETF (IXJ) stake by 3.5% in Q3 2024, buying an estimated $216K and bringing the position to 66,445 shares worth $6.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Raymond James & Associates first reported a position in IXJ in Q2 2013 and has held it in 39 quarters since. The position peaked at $8.23M in Q1 2018. 273 funds tracked by Wall St. Rank hold IXJ as of Q3 2024.

  • Raymond James & Associates held 66,445 shares of iShares Global Healthcare ETF worth $6.52M as of Q3 2024.
  • Raymond James & Associates bought 2,223 iShares Global Healthcare ETF shares in Q3 2024, an estimated $216K.
  • iShares Global Healthcare ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1474 holding.
  • Raymond James & Associates first reported a position in iShares Global Healthcare ETF in Q2 2013 and has held it in 39 quarters since.
  • Raymond James & Associates's iShares Global Healthcare ETF position peaked at $8.23M in Q1 2018.
  • 273 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.